N.LoorJ
But, McIntyre cautions, despite these encouraging preliminary results, these medications are not proven psychiatric treatments, and they are not ready for prime time
For Providers IGF-1 LR3 represents a powerful tool in sports medicine, rehabilitation, and age-management medicine
If you eat significantly more than your body needs while taking a GLP-1 drug, youll be fighting the appetite suppression rather than working with it, and youre more likely to feel unwell than to lose weight
Research Highlight Published: GLP-1 receptor agonism Nature Aging volume 6 , pages 2728 (2026) Cite this article 729 Accesses 1 Citations 2 Altmetric Metrics details Regarding the recently announced failure of a GLP-1RA trial in clinical stage Alzheimers disease, we believe this highlights the need for a strategic shift, not an abandonment of the drug class in neurodegeneration, says Ho Ko, co-corresponding author of the study